Cargando…
Effect of efflux pump inhibitors on drug susceptibility of ofloxacin resistant Mycobacterium tuberculosis isolates
BACKGROUND & OBJECTIVES: In drug resistant, especially multi-drug resistant (MDR) tuberculosis, fluoroquinolones (FQs) are used as second line drugs. However, the incidence of FQ-resistant Mycobacterium tuberculosis is rapidly increasing which may be due to extensive use of FQs in the treatment...
Autores principales: | Singh, Mradula, Jadaun, G.P.S., Ramdas, Srivastava, K., Chauhan, Vipin, Mishra, Ritu, Gupta, Kavita, Nair, Surya, Chauhan, D.S., Sharma, V.D., Venkatesan, K., Katoch, V.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121286/ https://www.ncbi.nlm.nih.gov/pubmed/21623040 |
Ejemplares similares
-
Ofloxacin-induced hallucinations
por: Chauhan, Urmila, et al.
Publicado: (2013) -
Efflux pump inhibitor combined with ofloxacin decreases MRSA biofilm formation by regulating the gene expression of NorA and quorum sensing
por: Lu, Xueer, et al.
Publicado: (2023) -
Molecular typing of Mycobacterium leprae strains from northern India using short tandem repeats
por: Lavania, Mallika, et al.
Publicado: (2011) -
Mycobacterium indicus pranii as stand-alone or adjunct immunotherapeutic in treatment of experimental animal tuberculosis
por: Faujdar, Jaya, et al.
Publicado: (2011) -
Efflux pumps and antimicrobial resistance: Paradoxical components in systems genomics
por: Kabra, Ritika, et al.
Publicado: (2019)